Back to results
US 2012/0071340 A1Published application
Biomarkers
AssigneePsynova Neurotech Ltd.
InventorsSabine Bahn, Emanuel Schwarz
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of diagnosing or monitoring major depressive disorder.
Claims24
Use of IL-17, IgA, Cortisol (CORT), Apolipoprotein A1, IL-6, Complement 3 (C3), Factor VII, Serum Amyloid P (SAP or APCS), Beta 2 Microglobulin, ICAM-1, IL-1 beta, TNF alpha, MIF, Angiotensinogen, NrCAM (Neuronal cell adhesion molecule), CD40, Cancer Antigen 125 (CA125), HCC 4 (CCL6;
- SCYA6), Eotaxin 3 (CCL26 or SCYA26), VEGF, Haptoglobin (HP), IL-1 alpha, Apolipoprotein H (Beta-2 Glycoprotein) and TIMP 1 as a specific panel of analyte biomarkers for major depressive disorder, or predisposition thereto.
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.